Literature DB >> 33400084

SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?

Dhanya Krishnan1, Ramsekhar N Menon2, Srinivas Gopala3.   

Abstract

SHANK- associated RH domain-interacting protein (SHARPIN) is a multifunctional protein associated with numerous physiological functions and many diseases. The primary role of the protein as a LUBAC-dependent component in regulating the activation of the transcription factor NF-κB accounts to its role in inflammation and antiapoptosis. Hence, an alteration of SHARPIN expression or genetic mutations or polymorphisms leads to the alteration of the above-mentioned primary physiological functions contributing to inflammation-associated diseases and cancer, respectively. However, there are complications of targeting SHARPIN as a therapeutic approach, which arises from the wide-range of LUBAC-independent functions and yet unknown roles of SHARPIN including neuronal functions. The identification of SHARPIN as a postsynaptic protein and the emerging studies indicating its role in several neurodegenerative diseases including Alzheimer's disease suggests a strong role of SHARPIN in neuronal functioning. This review summarizes the functional roles of SHARPIN in normal physiology and disease pathogenesis and strongly suggests a need for concentrating more studies on identifying the unknown neuronal functions of SHARPIN and hence its role in neurodegenerative diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-beta; Inflammation; NEMO; NLRP3; SHARPIN

Mesh:

Substances:

Year:  2021        PMID: 33400084     DOI: 10.1007/s10571-020-01023-w

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  127 in total

1.  Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex.

Authors:  S Mehdi Belgnaoui; Suzanne Paz; Sara Samuel; Marie-Line Goulet; Qiang Sun; Marjolein Kikkert; Kazuhiro Iwai; Ivan Dikic; John Hiscott; Rongtuan Lin
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

2.  Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.

Authors:  Elodie Bal; Emmanuel Laplantine; Yamina Hamel; Virginie Dubosclard; Bertrand Boisson; Alessandra Pescatore; Capucine Picard; Smaïl Hadj-Rabia; Ghislaine Royer; Julie Steffann; Jean-Paul Bonnefont; Valeria M Ursini; Pierre Vabres; Arnold Munnich; Jean-Laurent Casanova; Christine Bodemer; Robert Weil; Fabrice Agou; Asma Smahi
Journal:  J Allergy Clin Immunol       Date:  2017-02-27       Impact factor: 10.793

3.  Genome-wide copy number variation analysis of a Branchio-oto-renal syndrome cohort identifies a recombination hotspot and implicates new candidate genes.

Authors:  Patrick D Brophy; Fatemeh Alasti; Benjamin W Darbro; Jason Clarke; Carla Nishimura; Bryan Cobb; Richard J Smith; J Robert Manak
Journal:  Hum Genet       Date:  2013-07-13       Impact factor: 4.132

4.  SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides.

Authors:  Biao Chen; Yan Zheng; Jingna Zhu; Yanhua Liang
Journal:  Exp Dermatol       Date:  2019-09-10       Impact factor: 3.960

5.  Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC).

Authors:  Francisco Aguilar-Alonso; Amanda L Whiting; Ye Joon Kim; Federico Bernal
Journal:  Bioorg Med Chem       Date:  2017-12-05       Impact factor: 3.641

6.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

Review 7.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.

Authors:  Holly M Brothers; Maya L Gosztyla; Stephen R Robinson
Journal:  Front Aging Neurosci       Date:  2018-04-25       Impact factor: 5.750

8.  A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease.

Authors:  Yuya Asanomi; Daichi Shigemizu; Akinori Miyashita; Risa Mitsumori; Taiki Mori; Norikazu Hara; Kaoru Ito; Shumpei Niida; Takeshi Ikeuchi; Kouichi Ozaki
Journal:  Mol Med       Date:  2019-06-20       Impact factor: 6.354

9.  Linear ubiquitin assembly complex regulates lung epithelial-driven responses during influenza infection.

Authors:  Patricia L Brazee; Luisa Morales-Nebreda; Natalia D Magnani; Joe Gn Garcia; Alexander V Misharin; Karen M Ridge; G R Scott Budinger; Kazuhiro Iwai; Laura A Dada; Jacob I Sznajder
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

10.  A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.

Authors:  Victor M Bii; Dustin T Rae; Grant D Trobridge
Journal:  Oncotarget       Date:  2015-11-24
View more
  1 in total

1.  A functional variant of SHARPIN confers increased risk of late-onset Alzheimer's disease.

Authors:  Yuya Asanomi; Daichi Shigemizu; Shintaro Akiyama; Akinori Miyashita; Risa Mitsumori; Norikazu Hara; Takeshi Ikeuchi; Shumpei Niida; Kouichi Ozaki
Journal:  J Hum Genet       Date:  2021-11-05       Impact factor: 3.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.